Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
about
Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancerAnaplastic thyroid cancers harbor novel oncogenic mutations of the ALK geneLessons learned from next-generation sequencing in head and neck cancerFrequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkersToward the use of precision medicine for the treatment of head and neck squamous cell carcinomaOncogenic mutations of PIK3CA in human cancersGenome stability pathways in head and neck cancersThe determinants of head and neck cancer: Unmasking the PI3K pathway mutationsNovel insight into mutational landscape of head and neck squamous cell carcinomaCopy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cellsMutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian originPIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stabilityEGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapyPIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients.Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.PTEN deficiency contributes to the development and progression of head and neck cancer.Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.Dysregulated molecular networks in head and neck carcinogenesisAltered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets.Activation of the NOTCH pathway in head and neck cancer.Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.Oral cavity and oropharyngeal squamous cell carcinoma genomics.ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition.Genomic sequencing and precision medicine in head and neck cancers.Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.
P2860
Q54076889-11BDD0DD-A5DF-4FDB-BD98-E5CDAB465CA0Q54808305-6727DEA8-70B5-4C2B-B7D1-914FD76E0FE3Q54890111-22DB6CC6-00B7-4997-9667-095BBAA47DA1Q54890114-D67BD807-377A-4E08-86A9-BFA64B8F1AB5Q54890116-DD824A54-33C8-4B1D-A42B-2E32D7618FEAQ54890120-0B153F27-8450-4B0A-ADF0-D379D4C065CEQ54890121-E3EC3A5F-6332-44E5-9189-61A82C510B77Q54896384-BD2D4120-9FE5-4C05-A063-59770E88825AQ54896390-0355DB88-3030-487A-BD42-A0EC0CB7114DQ54896402-C7E12663-8F5F-48C9-A7DB-5F58B9E604CBQ54896408-E866BABC-25E3-4AB7-8957-804C9EF97CCFQ54896411-670E3D95-925C-442D-8816-A2186633DB25Q54907353-51537EFB-E9F6-4354-97C1-6AB9AB3A3F16
P1343
Q24300323-623F5BAC-9C6D-44B9-8603-7E0703940084Q24598210-8A1CEF6F-114D-4B86-B0B9-31E8EA599FC2Q27009209-EC30D83D-8E57-4C69-B1AE-7B983D18EE82Q27852227-74499EB5-F161-4328-B3F1-F2AF0BBD4025Q28074691-08504229-0251-40D5-8801-C1A0DECACD8AQ28284802-EA0D395D-5BAD-450C-9AFA-BA0942C3BBF5Q28391355-277142FF-2B64-4523-9900-622F6B1E6D05Q30365726-9AF245E4-B1FB-41E9-B8C6-46A10A742E36Q30441193-66C7879D-53DA-473C-A3BD-ADD2E65D35BBQ31096247-AD4827FC-8EA4-4FFB-8FA5-933C4E1FAAE6Q33839529-1E17AB16-7A6A-4B9C-AB75-C7EBAFE17B11Q33894100-0C9D8487-CD98-4E73-A4CF-CE87B33B79EDQ35041632-F76237D5-FF08-4067-8198-F5DB4CFCE939Q35068192-7EB268F6-E3A8-40D5-91B0-6C2858EA885DQ35103648-83F41312-774C-4E4B-AF15-38944C3E95EAQ35275603-6522744A-3F6E-45F3-B3D4-C42120C01891Q36103054-80BC059A-5EE4-41CA-8205-D3A26E9DA4EDQ36371231-0E3349D5-319B-4239-9CE3-387C0402AD24Q36774665-D3505D0E-7478-455C-BB61-B9E6D21EA6DCQ36801074-49174AAD-23C1-4CF8-BC37-5E362AABC41BQ37164556-EBD64EEE-8E93-4841-9731-B1FFFB2B1F89Q37274623-175285F8-2BA5-4BC9-993F-1902FC381F2BQ37339508-8CF8F902-CEB9-489B-9A76-9ADBACD794E1Q37621332-F16D2E92-D1E7-4244-BA09-2079E0754F6EQ37641638-004CBB65-73F2-4672-8716-CA2E762E8C1AQ38126153-E9F8B21B-7141-4746-871E-6BAE1B77FD34Q38607113-E8F89FA4-1B24-42B7-BCFD-2FE85D8C18F2Q38776454-07A64F22-1AA1-4470-9739-00728E91B90BQ39466612-935F707A-8142-4CF9-99A7-45C1C78E8864Q42545098-BDFF707F-0465-428D-AEFE-F83207376C59Q55518643-23AF5818-F537-4027-85A7-1B001539D888
P2860
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
@en
type
label
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
@en
prefLabel
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
@en
P2093
P1476
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
@en
P2093
Arasambattu Kannan Munirajan
Avaniyapuram Kannan Murugan
Nguyen Thi Hong
Nobuo Tsuchida
Yasuhisa Fukui
P304
P577
2008-01-01T00:00:00Z